Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

Georg Hess; Simon Rule; Wojciech Jurczak; Mats Jerkeman; Rodrigo Santucci Silva; Chiara Rusconi; Dolores Caballero; Cristina Joao; Mathias Witzens-Harig; Isabelle Bence-Bruckler; Seok-Goo Cho; Wenjiong Zhou; Jenna D. Goldberg; Cristina Trambitas; Christopher Enny; Jessica Vermeulen; Shana Traina; Chiun-Fang Chiou; Joris Diels; Martin Dreyling

doi:10.1080/10428194.2017.1326034

Health-related quality of life data from a phase 3, international, randomized, open-label, multicenter study in patients with previously treated mantle cell lymphoma treated with ibrutinib versus temsirolimus

Leukemia & Lymphoma ◽

10.1080/10428194.2017.1326034 ◽

2017 ◽

Vol 58 (12) ◽

pp. 2824-2832 ◽

Cited By ~ 8

Author(s):

Georg Hess ◽

Simon Rule ◽

Wojciech Jurczak ◽

Mats Jerkeman ◽

Rodrigo Santucci Silva ◽

...

Keyword(s):

Cell Lymphoma ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Life Data ◽

Mantle Cell ◽

Related Quality ◽

Health Related ◽

Previously Treated

Download Full-text

Health-Related Quality of Life of Blinatumomab for Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in a Randomized, Open-Label Phase 3 Study (TOWER): A Subgroup Analysis By Prior Allogeneic Hematopoietic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation ◽

10.1016/j.bbmt.2018.12.073 ◽

2019 ◽

Vol 25 (3) ◽

pp. S8-S9

Author(s):

Xinke Zhang ◽

Andre C. Schuh ◽

Ze Cong ◽

Max S. Topp ◽

Zachary Zimmerman ◽

...

Keyword(s):

Lymphoblastic Leukemia ◽

Health Related Quality ◽

Cell Precursor ◽

Open Label ◽

Phase 3 ◽

Hematopoietic Stem ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

Poster: CML-417: ASCEMBL Phase 3 Health-Related Quality of Life (HRQL) Comparison of Asciminib and Bosutinib for Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or More Tyrosine Kinase Inhibitors (TKI)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01412-9 ◽

2021 ◽

Vol 21 ◽

pp. S224

Author(s):

Michael J. Mauro ◽

Carla Boquimpani ◽

Delphine Réa ◽

Andreas Hochhaus ◽

Vikalp Kumar Maheshwari ◽

...

Keyword(s):

Quality Of Life ◽

Kinase Inhibitors ◽

Chronic Phase ◽

Myelogenous Leukemia ◽

Health Related Quality ◽

Phase 3 ◽

Related Quality ◽

Health Related ◽

Previously Treated

Download Full-text

Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(17)30690-3 ◽

2017 ◽

Vol 18 (12) ◽

pp. 1600-1609 ◽

Cited By ~ 118

Author(s):

Julie R Brahmer ◽

Delvys Rodríguez-Abreu ◽

Andrew G Robinson ◽

Rina Hui ◽

Tibor Csőszi ◽

...

Keyword(s):

Quality Of Life ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

CML-417: ASCEMBL Phase 3 Health-Related Quality of Life (HRQL) Comparison of Asciminib and Bosutinib for Patients with Chronic Myelogenous Leukemia in Chronic Phase (CML-CP), Previously Treated with 2 or More Tyrosine Kinase Inhibitors (TKI)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/s2152-2650(21)01785-7 ◽

2021 ◽

Vol 21 ◽

pp. S336

Author(s):

Michael J. Mauro ◽

Carla Boquimpani ◽

Delphine Réa ◽

Andreas Hochhaus ◽

Vikalp Kumar Maheshwari ◽

...

Keyword(s):

Quality Of Life ◽

Kinase Inhibitors ◽

Chronic Phase ◽

Myelogenous Leukemia ◽

Health Related Quality ◽

Phase 3 ◽

Related Quality ◽

Health Related ◽

Previously Treated

Download Full-text

3441 Randomized, open-label, multicenter, phase 3 study of eribulin versus dacarbazine in patients with leiomyosarcoma and adipocytic sarcoma: Health-related quality of life results

European Journal of Cancer ◽

10.1016/s0959-8049(16)31914-1 ◽

2015 ◽

Vol 51 ◽

pp. S702

Author(s):

H. Gelderblom ◽

J.Y. Blay ◽

D. D'Adamo ◽

S. Hudgens ◽

I. Kontoudis ◽

...

Keyword(s):

Quality Of Life ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Multicenter Phase ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(21)00064-4 ◽

2021 ◽

Author(s):

Thierry Andre ◽

Mayur Amonkar ◽

Josephine M Norquist ◽

Kai-Keen Shiu ◽

Tae Won Kim ◽

...

Keyword(s):

Quality Of Life ◽

Colorectal Cancer ◽

Mismatch Repair ◽

Health Related Quality ◽

First Line ◽

Open Label ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text

Health-related quality of life in patients with locally advanced or metastatic breast cancer treated with eribulin mesylate or capecitabine in an open-label randomized phase 3 trial

Breast Cancer Research and Treatment ◽

10.1007/s10549-015-3633-7 ◽

2015 ◽

Vol 154 (3) ◽

pp. 509-520 ◽

Cited By ~ 25

Author(s):

Javier Cortes ◽

Stacie Hudgens ◽

Chris Twelves ◽

Edith A. Perez ◽

Ahmad Awada ◽

...

Keyword(s):

Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Eribulin Mesylate ◽

Related Quality ◽

Health Related

Download Full-text

Pre‐treatment health‐related quality of life parameters have prognostic impact in patients > 65 years with newly diagnosed mantle cell lymphoma. The Nordic Lymphoma Group MCL4 (LENA‐BERIT) experience.

Hematological Oncology ◽

10.1002/hon.2940 ◽

2021 ◽

Author(s):

Åsa Lindberg ◽

Christian Winther Eskelund ◽

Alexandra Albertsson‐Lindblad ◽

Arne Kolstad ◽

Anna Laurell ◽

...

Keyword(s):

Quality Of Life ◽

Cell Lymphoma ◽

Prognostic Impact ◽

Newly Diagnosed ◽

Health Related Quality ◽

Mantle Cell ◽

Related Quality ◽

Health Related ◽

Pre Treatment

Download Full-text

Bortezomib, thalidomide, and dexamethasone with or without daratumumab for transplantation-eligible patients with newly diagnosed multiple myeloma (CASSIOPEIA): health-related quality of life outcomes of a randomised, open-label, phase 3 trial

The Lancet Haematology ◽

10.1016/s2352-3026(20)30356-2 ◽

2020 ◽

Vol 7 (12) ◽

pp. e874-e883

Author(s):

Murielle Roussel ◽

Philippe Moreau ◽

Benjamin Hebraud ◽

Kamel Laribi ◽

Arnaud Jaccard ◽

...

Keyword(s):

Quality Of Life ◽

Newly Diagnosed ◽

Health Related Quality ◽

Life Outcomes ◽

Open Label ◽

Phase 3 ◽

Open Label Phase ◽

Related Quality ◽

Health Related

Download Full-text

Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial

The Lancet Oncology ◽

10.1016/s1470-2045(15)00087-x ◽

2015 ◽

Vol 16 (13) ◽

pp. 1389-1398 ◽

Cited By ~ 122

Author(s):

Jean Jacques Grob ◽

Mayur M Amonkar ◽

Boguslawa Karaszewska ◽

Jacob Schachter ◽

Reinhard Dummer ◽

...

Keyword(s):

Quality Of Life ◽

Combination Therapy ◽

Randomised Trial ◽

Health Related Quality ◽

Open Label ◽

Phase 3 ◽

Related Quality ◽

Health Related

Download Full-text